These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24150262)

  • 1. PSA screening in New Zealand: total population results and general practitioners' current attitudes and practices.
    van Rij S; Dowell T; Nacey J
    N Z Med J; 2013 Aug; 126(1381):27-36. PubMed ID: 24150262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA testing in general practice.
    Hodgson F; Obertová Z; Brown C; Lawrenson R
    J Prim Health Care; 2012 Sep; 4(3):199-204. PubMed ID: 22946067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer: a survey of New Zealand general practitioners.
    Durham J; Low M; McLeod D
    N Z Med J; 2003 Jun; 116(1176):U476. PubMed ID: 12835804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening and informed decision-making: provider and patient perspectives.
    Bowen DJ; Hannon PA; Harris JR; Martin DP
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):155-61. PubMed ID: 21243007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer testing: a snapshot of the attitudes and practice of Australian general practitioners.
    Crowe J; Wootten AC; Howard N
    Aust J Prim Health; 2015; 21(1):111-4. PubMed ID: 24176263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial.
    Gattellari M; Donnelly N; Taylor N; Meerkin M; Hirst G; Ward JE
    Fam Pract; 2005 Jun; 22(3):253-65. PubMed ID: 15824055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for prostate cancer in New Zealand general practice.
    Zuzana O; Ross L; Fraser H; Charis B; Alistair S; Leanne T; Michael H; Peter G
    J Med Screen; 2013 Mar; 20(1):49-51. PubMed ID: 23612467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen testing: uncovering primary care influences.
    Gormley GJ; Catney D; McCall JR; Reilly PM; Gavin AT
    BJU Int; 2006 Nov; 98(5):996-1000. PubMed ID: 17034601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs of identifying undiagnosed prostate cancer in asymptomatic men in New Zealand general practice.
    Lao C; Brown C; Obertová Z; Edlin R; Rouse P; Hodgson F; Holmes M; Gilling P; Lawrenson R
    Fam Pract; 2013 Dec; 30(6):641-7. PubMed ID: 24055993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
    Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
    Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for prostate cancer: what do general practitioners think?
    Morris J; McNoe B
    N Z Med J; 1997 May; 110(1044):178-82. PubMed ID: 9201202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer screening: a survey of attitudes and practices among Finnish physicians in 1999 and 2007.
    Pogodin-Hannolainen D; Juusela H; Tammela TL; Ruutu M; Aro J; Määttänen L; Auvinen A
    J Med Screen; 2011; 18(1):46-9. PubMed ID: 21536817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database.
    D'Ambrosio GG; Campo S; Cancian M; Pecchioli S; Mazzaglia G
    Eur J Cancer Prev; 2010 Nov; 19(6):413-6. PubMed ID: 20679895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPs views and understanding of PSA testing, screening and early detection; survey.
    Sutton J; Melia J; Kirby M; Graffy J; Moss S
    Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.